The DOI matches its OpenAlex record; 18 of the 18 references it cites were found in a registry or an index.
Surgical Management of GH-Secreting Pituitary Adenomas: An Outcome Study Using Modern Remission Criteria
Open accessAbstract
The results of transsphenoidal surgery as initial therapy for GH-secreting pituitary adenomas in 57 acromegalic patients were analyzed retrospectively. Patients with prior surgery or radiation therapy were excluded from the study. Three different criteria were used to define remission: glucose-suppressed (nadir) GH less than 1.0 microg/liter, a normal sex- and age-adjusted IGF-I level, and postoperative random GH levels of 2.5 microg/liter or less. Additionally, we analyzed the neuropathological data, including immunohistochemistry and ultrastructural categorization, and the surgical complications. The short-term remission rate (6-wk postoperative follow-up visit), as determined by a random GH measurement of 2.5 microg/liter or less, was 48.8%; the remission rate, as determined by nadir GH, was 51.4%. For 57 patients followed for 12 months or more after surgery (mean, 37.7 months), surgical remission was achieved in 70.2%, 66.7%, and 61.1%, respectively, for patients assessed by normal IGF-I, random GH, and nadir GH. One patient (1.1%) developed recurrence of active acromegaly 81 months after initially successful surgical therapy. Extrasellar growth of the tumor (P = 0.04) and dural invasion by the adenoma (P = 0.008) were significant univariate predictors of a poor outcome. Tumor size was significantly greater in patients with persistent or recurrent acromegaly (P = 0.02). Patients with tumors of the ultrastructural categories of mixed GH/PRL cell and mammosomatotroph adenomas had the lowest remission rates (50% and 42.9%, respectively). There were no perioperative deaths, and there was no serious morbidity. The permanent complication rate was 3.3% (1 permanent DI and 2 nasal septal perforations). Surgical management of acromegaly currently provides prompt, effective, and satisfactory initial treatment for the majority of patients. Using stringent criteria for remission, primary transsphenoidal surgery for GH-secreting pituitary adenomas is effective and often definitive therapy for acromegaly. These results provide a benchmark for the contemporary results of surgical management as assessed by modern outcome criteria.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Criteria for Cure of Acromegaly: A Consensus Statement
Giustina, A. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.2.526 · Cited by 987
Long-Term Mortality after Transsphenoidal Surgery and Adjunctive Therapy for Acromegaly1
Swearingen, B., Barker, F. G., Katznelson, L., Biller, B. M. K., Grinspoon, S., Klibanski, A., Moayeri, N., Black, P. M., & Zervas, N. T. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.10.5222 · Cited by 586
Determinants of clinical outcome and survival in acromegaly
Rajasoorya, C., Holdaway, I. M., Wrightson, P., Scott, D. J., & Ibbertson, H. K. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb03789.x · Cited by 565
Wright, A. D., Hill, D. M., Lowy, C., & Fraser, T. R. (1970) · PubMed · Cited by 529
An audit of outcome of treatment in acromegaly
(1993) · QJM: An International Journal of Medicine · doi:10.1093/oxfordjournals.qjmed.a068816 · Cited by 466
Long-Term Mortality after Transsphenoidal Surgery and Adjunctive Therapy for Acromegaly
Swearingen, B. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.10.3419 · Cited by 400
Abosch, A., Tyrrell, J. B., Lamborn, K. R., Hannegan, L. T., Applebury, C. B., & Wilson, C. B. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.10.3411 · Cited by 361
Transsphenoidal microsurgical removal of 250 pituitary adenomas
Wilson, C. B., & Dempsey, L. C. (1978) · Journal of Neurosurgery · doi:10.3171/jns.1978.48.1.0013 · Cited by 346
Freda, P. U., Wardlaw, S. L., & Post, K. D. (1998) · Journal of Neurosurgery · doi:10.3171/jns.1998.89.3.0353 · Cited by 281
Ross, D. A., & Wilson, C. B. (1988) · Journal of Neurosurgery · doi:10.3171/jns.1988.68.6.0854 · Cited by 260
Cited by
Acromegaly: An Endocrine Society Clinical Practice Guideline
Katznelson, L., Laws, E. R., Melmed, S., Molitch, M. E., Murad, M. H., Utz, A., & Wass, J. A. H. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2700 · Cited by 1,786
Self-citationClinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)
Thakker, R. V., Newey, P. J., Walls, G. V., Bilezikian, J., Dralle, H., Ebeling, P. R., Melmed, S., Sakurai, A., Tonelli, F., & Brandi, M. L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1230 · Cited by 1,477
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
Colao, A., Ferone, D., Marzullo, P., & Lombardi, G. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0022 · Cited by 1,309
Francis, G. L., Waguespack, S. G., Bauer, A. J., Angelos, P., Benvenga, S., Cerutti, J. M., Dinauer, C. A., Hamilton, J., Hay, I. D., Luster, M., et al. (2015) · Thyroid · doi:10.1089/thy.2014.0460 · Cited by 1,238
Melmed, S. (2006) · New England Journal of Medicine · doi:10.1056/nejmra062453 · Cited by 1,160
Acromegaly pathogenesis and treatment
Melmed, S. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39375 · Cited by 687
The 2017 World Health Organization classification of tumors of the pituitary gland: a summary
Lopes, M. B. S. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1769-8 · Cited by 548
Self-citationBarker, F. G., Klibanski, A., & Swearingen, B. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030461 · Cited by 506
The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical ‘cure’
Nomikos, P., Buchfelder, M., & Fahlbusch, R. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01863 · Cited by 500
Dehdashti, A. R., Ganna, A., Karabatsou, K., & Gentili, F. (2008) · Neurosurgery · doi:10.1227/01.neu.0000297072.75304.89 · Cited by 408
Systemic Complications of Acromegaly and the Impact of the Current Treatment Landscape: An Update
Gadelha, M. R., Kasuki, L., Lim, D. S. T., & Fleseriu, M. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00115 · Cited by 363
Roelfsema, F., Biermasz, N. R., & Pereira, A. M. (2012) · Pituitary · doi:10.1007/s11102-011-0347-7 · Cited by 346
Late Recurrences of Cushing’s Disease after Initial Successful Transsphenoidal Surgery
Patil, C. G., Prevedello, D. M., Lad, S. P., Vance, M. L., Thorner, M. O., Katznelson, L., & Laws, E. R. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2013 · Cited by 320
Self-citationAggressive pituitary adenomas—diagnosis and emerging treatments
Di Ieva, A., Rotondo, F., Syro, L. V., Cusimano, M. D., & Kovacs, K. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.64 · Cited by 318
Jane, J. A., Starke, R. M., Elzoghby, M. A., Reames, D. L., Payne, S. C., Thorner, M. O., Marshall, J. C., Laws, E. R., & Vance, M. L. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0554 · Cited by 316
Self-citationThe Endoscopic versus the Traditional Approach in Pituitary Surgery
Frank, G., Pasquini, E., Farneti, G., Mazzatenta, D., Sciarretta, V., Grasso, V., & Faustini Fustini, M. (2006) · Neuroendocrinology · doi:10.1159/000095534 · Cited by 306
Results of Transsphenoidal Surgery in a Large Series of Patients with Pituitary Adenoma
Mortini, P., Losa, M., Barzaghi, R., Boari, N., & Giovanelli, M. (2005) · Neurosurgery · doi:10.1227/01.neu.0000159647.64275.9d · Cited by 305
Zada, G., Kelly, D. F., Cohan, P., Wang, C., & Swerdloff, R. (2003) · Journal of Neurosurgery · doi:10.3171/jns.2003.98.2.0350 · Cited by 302
Ammirati, M., Wei, L., & Ciric, I. (2013) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-303194 · Cited by 302
(2011) · Endocrine Practice · doi:10.4158/ep.17.s4.1 · Cited by 259
Outcomes of proton therapy for patients with functional pituitary adenomas
Wattson, D. A., Tanguturi, S. K., Spiegel, D. Y., Niemierko, A., Biller, B. M. K., Nachtigall, L. B., Bussière, M. R., Swearingen, B., Chapman, P. H., Loeffler, J. S., et al. (2014) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2014.06.068 · Cited by 125
Pituitary insufficiency after traumatic brain injury
Wachter, D., Gündling, K., Oertel, M. F., Stracke, H., & Böker, D.-K. (2009) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2008.01.009 · Cited by 62
“In other studies, neuropsychological disorders, including fatigue, frustration and concentration deficits were identified in 42% of TBI patients.(13,14) GHD are thought to be the major cause of diverse post-traumatic”
BackgroundClinical predictors of GH deficiency in surgically cured acromegalic patients
Ku, C. R., Hong, J. W., Kim, E. H., Kim, S. H., & Lee, E. J. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0304 · Cited by 24
Metadata
- Authors
- Kreutzer, J., Vance, M. L., Lopes, M. B. S., & Laws, E. R.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- Oxford University Press
- Published
- 2001-09-01
- Volume
- 86
- Issue
- 9
- Pages
- 4072-4077
- ISSN
- 0021-972X (ISSN-L)
- OpenAlex
- W2166601702
- Cited by
- 341
- References
- 18
- FWCI
- 8.29
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.